Neth Heart J. 2002 Jun;10(6):272-276.

DDDR pacing for symptomatic patients with hypertrophic obstructive cardiomyopathy: The first experience in the Netherlands with pacing in HOCM.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

H J Achterberg, M G Scheffer, R van Mechelen, M J M Kofflard, F J Ten Cate

PMID: 25696108 PMCID: PMC2499779

Abstract

BACKGROUND: Hypertrophic obstructive cardiomyopathy (HOCM) is a primary cardiac disorder with a heterogeneous expression. When medical therapy fails in patients with symptomatic HOCM, three additional therapeutic strategies exist: ventricular septal myectomy, alcohol-induced percutaneous transluminal septal myocardial ablation (PTSMA) of the first septal branch of the anterior descending artery and pacemaker implantation. In this paper we present the results of seven patients in whom a dual-chamber pacemaker was implanted to reduce the gradient in the left ventricular outflow tract (LVOT) and to relieve their symptoms.

METHODS: In patients with drug refractory symptomatic HOCM, not eligible for surgery, pacemaker therapy was recommended. Symptomatic HOCM was defined as symptoms of angina and dyspnoea, functional class NYHA 3-4 and a resting LVOT gradient during Doppler echocardiography of more than 2.75 m/s (30 mmHg). In these patients, a dual-chamber pacemaker was implanted with a right ventricular lead positioned in the right ventricular apex and an atrial lead positioned in the right atrial appendage. In all patients the AV setting was programmed between 50 and 100 ms, using Doppler echocardiography to determine the optimal filling and to ensure ventricular capture.

RESULTS: A statistically significant reduction of the LVOT gradient was observed in all patients. The pre-implantation gradient in the LVOT measured by Doppler echocardiography varied from 3-5.8 m/s with a mean of 4.7±1.1 m/s. The post-implantation gradient varied from 1.4-2.6 m/s with a mean of 1.9±0.4 m/s (p<0.001). Symptomatic improvement was present in all patients. NYHA functional class went from 3-4 (mean 3.1±0.5) pre-implantation to 1-2 mean (1.3±0.4) after implantation (p<0.001). During a mean follow-up of 2.3±1.1 years, the improvement in functional class was maintained.

CONCLUSION: Our preliminary results demonstrate that dual-chamber pacing is an effective and safe treatment for symptomatic patients with HOCM.

Keywords: DDDR pacing; hypertrophic obstructive cardiomyopathy

References

1. Heart. 2001 Dec;86(6):709-14 - PubMed
2. Am J Cardiol. 1994 Mar 15;73(8):571-6 - PubMed
3. J Am Coll Cardiol. 1998 Feb;31(2):259-64 - PubMed
4. Circulation. 1998 Jan 27;97(3):230-3 - PubMed
5. Lancet. 1992 May 30;339(8805):1318-23 - PubMed
6. Lancet. 1995 Jul 22;346(8969):211-4 - PubMed
7. J Am Coll Cardiol. 1999 Oct;34(4):1117-22 - PubMed
8. J Am Coll Cardiol. 1998 Feb;31(2):252-8 - PubMed
9. Am J Cardiol. 1979 Jun;43(6):1242-4 - PubMed
10. Circulation. 1992 Jun;85(6):2149-61 - PubMed
11. J Am Coll Cardiol. 1996 Jul;28(1):197-202 - PubMed
12. Circulation. 1994 Dec;90(6):2731-42 - PubMed
13. Circulation. 1989 Nov;80(5):1259-68 - PubMed
14. J Am Coll Cardiol. 1999 May;33(6):1735-42 - PubMed
15. Eur Heart J. 1997 Aug;18(8):1249-56 - PubMed
16. Am J Cardiol. 1999 Mar 15;83(6):903-7 - PubMed
17. Chest. 1997 Jul;112(1):262-4 - PubMed
18. Circulation. 1998 Dec 1;98(22):2415-21 - PubMed
19. Circulation. 1989 Nov;80(5):1489-92 - PubMed
20. Hypertension. 2001 Dec 1;38(6):1278-81 - PubMed
21. Circulation. 1999 Jun 8;99(22):2927-33 - PubMed
22. Circulation. 1989 Apr;79(4):766-75 - PubMed

Publication Types

• Journal Article